ETIOLOGIC CANCER RESEARCH IN A POPULATION-BASED COHORT
基于人群的癌症病因研究
基本信息
- 批准号:2108468
- 负责人:
- 金额:$ 3.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-09-20 至 1998-08-31
- 项目状态:已结题
- 来源:
- 关键词:all trans retinol ascorbate aspirin biomarker blood lipid breast neoplasms cancer risk chronic obstructive pulmonary disease colon neoplasms dietary lipid environment related neoplasm /cancer human middle age (35-64) human population study human subject insulin insulinlike growth factor interview longitudinal human study lung neoplasms neoplasm /cancer diagnosis neoplasm /cancer epidemiology neoplasm /cancer genetics prostate neoplasms tocopherols
项目摘要
We propose a cost-effective expansion of a population-based cohort study,
the Atherosclerosis Risk in Communities (ARIC) Study, to encompass
etiologic cancer research. A total of 15,000 middle-aged adults, blacks
and whites, sampled from four U.S. communities were first examined in
1987-1989. Many known or potential risk factors for common cancers were
carefully measured in the baseline examination, and biologic specimens
(sera, plasma, blood cells, and DNA) were stored. Three subsequent
examinations have been funded: 1990-1992, 1993-1995, and 1996-1998.
Participants have reported cancer occurrence at every examination and have
annually reported all hospitalizations, including those for cancer. About
450 cancers are estimated to have occurred by 1992, an average follow-up
of four years.
The ARIC Study is likely to continue long-term, so expanding it to include
cancer endpoints is cost-effective. There are five specific aims for this
three-year project. First, we propose in Year 01 to augment information on
established risk factors for common cancers (breast, lung, colon, and
prostate) by means of a phone interview. Second, we propose to expand
ARIC's rudimentary system for finding incident cancer cases by linking, in
Years 01 and 03, cohort identifiers to cancer registries, available in
three of the four source communities, and by collecting in Years 01
through 03 cancer-related hospitalizations of cohort members. Third, a
trained nurse abstractor will abstract information on the estimated 700
incident cancers that will have occurred between January 1987 and December
1994 (an average of follow-up of over six years). Fourth, in Year 03 we
will test specific hypotheses related to 1) the independent etiologic role
of body fat distribution, body mass, endogenous insulin, and lipid levels
in breast cancer, and 2) whether chronic obstructive lung disease is a
risk marker for lung cancer independent of smoking intensity. The fifth,
and broader, aim is to establish cancer as a reliable endpoint in the ARIC
cohort for future studies of genetic and environmental risk factors and
their interactions.
The proposed project, which takes advantage of an already established
large population-based cohort, requires relatively little support and yet
will contribute substantially to the etiologic research of common cancers
during this project and far beyond it.
我们建议对基于人群队列研究进行经济有效的扩展,
社区动脉粥样硬化风险(ARIC)研究,包括
癌症病因学研究。总共有15,000名中年人,黑人
和白人,他们首先在
1987-1989.常见癌症的许多已知或潜在危险因素
在基线检查中仔细测量,生物标本
(sera血浆、血细胞和DNA)。三个后续
为1990-1992年、1993-1995年和1996-1998年的考试提供了经费。
参与者在每次检查时报告癌症发生,并
每年报告所有住院,包括癌症住院。关于
到1992年估计发生了450起癌症,平均随访
四年。
ARIC研究可能会长期持续下去,因此将其扩展到包括
癌症终点的成本效益。为此有五个具体目标
为期三年的项目。首先,我们建议在2001年增加以下信息:
常见癌症(乳腺癌、肺癌、结肠癌和肺癌)的已确定风险因素
前列腺)。第二,我们建议扩大
ARIC的基本系统,用于通过将
2001年和2003年,癌症登记研究的队列标识符,可在
四个源群落中的三个,并通过在2001年收集
至03例癌症相关住院治疗的队列成员。三是
经过培训的护士文摘员将对估计的700份资料进行文摘
在1987年1月至12月间发生的癌症
1994年(平均随访6年以上)。第四,在03年,我们
将检验与1)独立病因学作用相关的特定假设
体内脂肪分布、体重、内源性胰岛素和血脂水平
2)慢性阻塞性肺疾病是否是乳腺癌的一个
与吸烟强度无关肺癌危险标记物。第五、
和更广泛的目标是将癌症确定为ARIC中的可靠终点
未来研究遗传和环境风险因素的群组,以及
他们的互动。
拟议的项目利用了一个已经建立的
基于人口的大群体,需要相对较少的支持,但
将为常见癌症的病因学研究做出重要贡献
在这个项目中,甚至更远的时候。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eyal Shahar其他文献
Eyal Shahar的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eyal Shahar', 18)}}的其他基金
COMMUNITY SURVEILLANCE OF CONGESTIVE HEART FAILURE
充血性心力衰竭的社区监测
- 批准号:
6185034 - 财政年份:1998
- 资助金额:
$ 3.66万 - 项目类别:
COMMUNITY SURVEILLANCE OF CONGESTIVE HEART FAILURE
充血性心力衰竭的社区监测
- 批准号:
6390045 - 财政年份:1998
- 资助金额:
$ 3.66万 - 项目类别:
COMMUNITY SURVEILLANCE OF CONGESTIVE HEART FAILURE
充血性心力衰竭的社区监测
- 批准号:
6537451 - 财政年份:1998
- 资助金额:
$ 3.66万 - 项目类别:
COMMUNITY SURVEILLANCE OF CONGESTIVE HEART FAILURE
充血性心力衰竭的社区监测
- 批准号:
6030926 - 财政年份:1998
- 资助金额:
$ 3.66万 - 项目类别:
ETIOLOGIC CANCER RESEARCH IN A POPULATION-BASED COHORT
基于人群的癌症病因研究
- 批准号:
2517607 - 财政年份:1995
- 资助金额:
$ 3.66万 - 项目类别:
ETIOLOGIC CANCER RESEARCH IN A POPULATION-BASED COHORT
基于人群的癌症病因研究
- 批准号:
2108469 - 财政年份:1995
- 资助金额:
$ 3.66万 - 项目类别:
相似海外基金
Mechanisms of organ dysfunction and recovery in the Acetaminophen and Ascorbate Trial in Sepsis
对乙酰氨基酚和抗坏血酸脓毒症试验中器官功能障碍和恢复的机制
- 批准号:
10502613 - 财政年份:2022
- 资助金额:
$ 3.66万 - 项目类别:
Mechanisms of organ dysfunction and recovery in the Acetaminophen and Ascorbate Trial in Sepsis
对乙酰氨基酚和抗坏血酸脓毒症试验中器官功能障碍和恢复的机制
- 批准号:
10644023 - 财政年份:2022
- 资助金额:
$ 3.66万 - 项目类别:
Ascorbate and glutathione integrate the control of grapevine development
抗坏血酸和谷胱甘肽整合控制葡萄树的发育
- 批准号:
DP210102178 - 财政年份:2022
- 资助金额:
$ 3.66万 - 项目类别:
Discovery Projects
Finessing, Extending and Developing an Overview of the Regulation of Ascorbate in plants (FEDORA)
精炼、扩展和发展植物中抗坏血酸的调控概述 (FEDORA)
- 批准号:
BB/W006553/1 - 财政年份:2022
- 资助金额:
$ 3.66万 - 项目类别:
Research Grant
Finessing, Extending and Developing an Overview of the Regulation of Ascorbate in plants (FEDORA)
精炼、扩展和发展植物中抗坏血酸的调控概述 (FEDORA)
- 批准号:
BB/W006707/1 - 财政年份:2022
- 资助金额:
$ 3.66万 - 项目类别:
Research Grant
The role of ascorbate in myelopoiesis and infection
抗坏血酸在骨髓生成和感染中的作用
- 批准号:
10582571 - 财政年份:2021
- 资助金额:
$ 3.66万 - 项目类别:
The role of ascorbate in myelopoiesis and infection
抗坏血酸在骨髓生成和感染中的作用
- 批准号:
10210088 - 财政年份:2021
- 资助金额:
$ 3.66万 - 项目类别:
The role of ascorbate in myelopoiesis and infection
抗坏血酸在骨髓生成和感染中的作用
- 批准号:
10374915 - 财政年份:2021
- 资助金额:
$ 3.66万 - 项目类别:
Regulation of light-dependent synthesis of L-ascorbate in plants
植物中 L-抗坏血酸光依赖性合成的调控
- 批准号:
19K06702 - 财政年份:2019
- 资助金额:
$ 3.66万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Reversing age-related reductions in heat loss responses via the administration of ascorbate
通过服用抗坏血酸逆转与年龄相关的热损失反应减少
- 批准号:
525181-2018 - 财政年份:2018
- 资助金额:
$ 3.66万 - 项目类别:
University Undergraduate Student Research Awards














{{item.name}}会员




